logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Alkem Laboratories Share Price

Alkem Laboratories Ltd.

₹5,288

-11.00(-0.21%)

Invest in ALKEM with up to 4.00x margin.

Trade with MTF
1st Apr 2026 | 1:02 PM
NSE : ALKEM
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Alkem Laboratories Performance

Price Movement

₹5288.00

₹5246.50

₹5454.00

↘ Today's Low↗ Today's High

1 Year Performance

₹5288.00

₹4611.85

₹5933.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹5,454.00
Low₹5,246.50
Open at₹5,320.50
Prev Close₹5,299.00
Volumes62.06 K
Avg Price₹5,325.78
Lower Circuit₹4,769.50
Upper Circuit₹5,828.50

Historical Performance

3M High₹5,933.50
3M Low₹5,111.50
1 Yr High₹5,933.50
1 Yr Low₹4,611.85
3 Yr High₹6,439.90
3 Yr Low₹3,186.30
5 Yr High₹6,439.90
5 Yr Low₹2,670.10

Alkem Laboratories Fundamentals

Market Cap
High in industry
63,357.50 Cr.
PE Ratio (TTM)
Above industry Median
26.70
Dividend Yield
Above industry Median
1
Net Profit TTM
10.1% incr over last year
2,371.20
Net Profit Growth
10.1% incr over last year
2,371.20
PEG Ratio
High in industry
2.60
ROE
3.7% incr over last year
18.06
Operating Revenue TTM
14,252.70
Operating Revenue Growth
11.7% incr over last year
Book Value
Above industry Median
4.50
MFI
MFI oversold
24.98
RSI
RSI is mid-range
43.97
EPS (TTM)
181.11
Debt to Equity
0.09
Face Value
2
Operating Profit Margin Qtr.
18.67
Operating Profit Qtr.
828
Net Profit Qtr.
636.02
Operating Revenue Qtr.
3,736.82
PB Ratio
4.50

Alkem Laboratories Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue2,491.272,542.032,372.172,044.942,286.83
Operating Expense1,802.061,771.351,751.691,748.151,629
Operating Profit689.21770.68620.48296.79657.83
Depreciation60.9158.5958.8991.6467.61
Interest15.5112.7512.7916.9121
Tax84.0177.0557.4173.9562.17
Net Profit622.14786.73656.16276.94723.12

ALKEM Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹5,402 - ₹0

Target Price

₹5,980

Stop Loss

-

Target Date

16 Feb 27

Potential Returns

10.70 %

View Call ↗

Alkem Laboratories Technicals

Alkem Laboratories Ltd. EMA & SMA

₹5288.00

-56.50 (-1.06%)

↗ Bullish Moving Average

0

↘ Bearish Moving Average

16

Day EMA5 ₹5319.9
Day EMA10 ₹5334.8
Day EMA12 ₹5345.6
Day EMA20 ₹5390.4
Day EMA26 ₹5419.8
Day EMA50 ₹5493.3
Day EMA100 ₹5517.5
Day EMA200 ₹5450.7

Alkem Laboratories Support and Resistance

Resistance

First Resistance₹5345.67
Second Resistance₹5392.33
Third Resistance₹5439.17

Support

First Support₹5252.17
Second Support₹5205.33
Third Support₹5158.67

Technical Indicators

Day RSI43.97
Day MFI24.98
Day ADX18.16
Day Commodity Channel Index-66.10
William-66.12
Day MACD-74.23
Day MACD Signal Line-74.92
Day ATR138.73
Day ROC125-3.79
Day ROC21-5.80

Alkem Laboratories Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter55.755.755.15351.251.2
FII910.19.49.19.510
DII19.218.119.421.821.921.5
Public16.116.2161617.417.3

Alkem Laboratories Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day98.6 K1.84 L53.62%
Week64.61 K1.19 L54.50%
1 Month79.65 K1.3 L61.14%
6 Month85.94 K1.37 L62.78%

Alkem Laboratories SWOT Analysis

Strengths16
Weakness10
Opportunity2
Threats3

MACD Crossover Above Signal Line

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Mid-range Performer (DVM)

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

MACD crossed above signal line previous end of day

Volume Shockers

Alkem Laboratories Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
20 Feb, 202643INTERIM20 Feb, 2026Equity Share
08 Aug, 20258FINAL08 Aug, 2025Equity Share
14 Feb, 202537INTERIM14 Feb, 2025Equity Share
09 Aug, 20245FINAL10 Aug, 2024Equity Share
16 Feb, 202435INTERIM17 Feb, 2024Equity Share
10 Aug, 202310FINAL10 Aug, 2023Equity Share
17 Feb, 202325SPECIAL18 Feb, 2023Equity Share
17 Feb, 202315INTERIM18 Feb, 2023Equity Share
08 Aug, 20224FINAL10 Aug, 2022Equity Share
10 Feb, 202230INTERIM12 Feb, 2022Equity Share

Alkem Laboratories Stock Comparison

Financials
Anthem Biosciences Ltd.
J B Chemicals & Pharmaceuticals Ltd.
AstraZeneca Pharma India Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.
Pfizer Ltd.
Abbott India Ltd.
Price (₹)₹674.40₹2,009.60₹7,867₹2,335.60₹4,833.30₹26,405
% Change2.77%-2.65%1.31%2.30%2.39%1.89%
Revenue TTM (₹ Cr)₹1,996.59₹4,193.04₹2,177.45₹3,800.74₹2,482.33₹6,824.13
Net Profit TTM (₹ Cr)₹484.66₹753.78₹200.89₹1,020.99₹853.55₹1,524.13
PE TTM76.1044.0096.6037.9025.3036.10
1 Year Return15.1327.18-9.78-20.7417.88-15.64
ROCE26.8824.69-57.0322.93-

FAQ's on ALKEM

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy